Skip to main content
. 2022 Dec 5;1867(3):130288. doi: 10.1016/j.bbagen.2022.130288

Fig. 6.

Fig. 6

Schematic illustration of surface engineering of human heteropolymer ferritin with 12 different and randomly placed RBDs to represent the prospect of a universal mosaic ferritin nanocage vaccine candidate that could offer broader neutralizing antibody capability. This design could carry up to 24 RBDs and an antigenic peptide inside the protein cavity to improve immune response.